Epidemiology of HCV infection in the Central European region

Petr Urbánek; Pavol Kristian; Michael Makara; Bela Hunyady; Krzysztof Tomasiewicz

doi:10.5114/ceh.2016.58849

eISSN: 2449-8238
ISSN: 2392-1099

Clinical and Experimental Hepatology

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2016
vol. 2

Send email

Copy url:

abstract:

Review paper

Epidemiology of HCV infection in the Central European region

Petr Urbánek

,

Pavol Kristian

,

Michael Makara

,

Bela Hunyady

,

Krzysztof Tomasiewicz

Clinical and Experimental HEPATOLOGY 2016; 1: 2–6

DOI: https://doi.org/10.5114/ceh.2016.58849

Online publish date: 2016/03/24

View full text Get citation

PlumX metrics:

Opinion leaders in each of four countries in the Central European region summarize the available data on hepatitis C virus (HCV) epidemiology. The overall prevalence of anti-HCV antibody reactivity in this region varies between 0.2% and 2.1%, the most prevalent HCV genotype is GT 1. The commonest route of transmission is intravenous drug abuse at present.

keywords:

Epidemiology of HCV infection in the Central European region

Petr Urbánek , Pavol Kristian , Michael Makara , Bela Hunyady , Krzysztof Tomasiewicz

hepatitis C virus, prevalence

Petr Urbánek

,

Pavol Kristian

,

Michael Makara

,

Bela Hunyady

,

Krzysztof Tomasiewicz